Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India
Source link
Related
Tags: Sun Pharma
Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India
Source link
Sun Pharma Announces China NMPA Approval For ILUMETRI (Tildrakizumab Injection) For Treatment Of Adults with Moderate-To-Severe Plaque Psoriasis Source link
Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe,...
Sun Pharma to announce fourth quarter results on May 26, 2023 Source link
Osteoarthritis Candidate MM-II Showed Durable Pain Relief in Global Phase 2b Study Source link
Sun Pharma - Milmet Labs merger Source link
Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata...
ADANI Adani Enterprises Adani Group Aditya Birla Group Airtel Ambuja Cement Apollo Hospitals Apple Inc Bajaj Auto Bank of America Cigna Corporation Cognizant India Dabur India Dalmia Bharat Exxon Mobil FedEx Corp General Electric Godrej Group HAL Home Depot ICICI Bank Indian Bank Infosys Kubota Corporation L&T Mahindra & Mahindra Meta Platforms Microsoft National Aluminium Company Nestle India Royal Dutch Shell Samsung Global Saudi Aramco Standard Chartered Bank Steel Authority of India Sun Pharma Target Corporation Tata Chemicals Tata Consumer Products Tata Motors Tata Power Tata Steel UltraTech Limited Verizon Communications Voltas Limited
© 2022 incPres.com